Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) EBT: 2012-2016

Historic EBT for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to -$57.7 million.

  • Tvardi Therapeutics' EBT fell 8.55% to -$12.6 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$66.3 million, marking a year-over-year decrease of 46.44%. This contributed to the annual value of -$57.7 million for FY2016, which is 130.19% down from last year.
  • According to the latest figures from FY2016, Tvardi Therapeutics' EBT is -$57.7 million, which was down 130.19% from -$25.1 million recorded in FY2015.
  • In the past 5 years, Tvardi Therapeutics' EBT ranged from a high of -$4.0 million in FY2013 and a low of -$57.7 million during FY2016.
  • Its 3-year average for EBT is -$33.6 million, with a median of -$25.1 million in 2015.
  • Its EBT has fluctuated over the past 5 years, first soared by 36.64% in 2013, then tumbled by 349.44% in 2014.
  • Tvardi Therapeutics' EBT (Yearly) stood at -$6.3 million in 2012, then skyrocketed by 36.64% to -$4.0 million in 2013, then tumbled by 349.44% to -$17.9 million in 2014, then crashed by 39.79% to -$25.1 million in 2015, then tumbled by 130.19% to -$57.7 million in 2016.